Bone erosion in rheumatoid arthritis: mechanisms, diagnosis and treatment (original) (raw)

• Karsenty, G., Kronenberg, H. M. & Settembre, C. Genetic control of bone formation. Annu. Rev. Cell. Dev. Biol. 25, 629–648 (2009).
  Article CAS PubMed Google Scholar
• Teitelbaum, S. L. & Ross, F. P. Genetic regulation of osteoclast development and function. Nat. Rev. Genet. 4, 638–649 (2003).
  Article CAS PubMed Google Scholar
• Boyle, W. J., Simonet, W. S. & Lacey, D. L. Osteoclast differentiation and activation. Nature 423, 337–342 (2003).
  Article CAS PubMed Google Scholar
• Baker, W. M. The formation of abnormal synovial cysts in the connection with the joints. St Bartolomews Hospital Reports 21, 177–190 (1855).
  Google Scholar
• Weichselbaum, A. Die feineren Veränderungen des Gelenkknorpels bei fungöser Synovitis und Karies der Gelenkenden [German] Archiv. Pathol. Anat. Physiol. Klin. Med. 73, 461–475 (1878).
  Article Google Scholar
• Takayanagi, H. Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems. Nat. Rev. Immunol. 7, 292–304 (2007).
  Article CAS PubMed Google Scholar
• Arron, J. R. & Choi, Y. Osteoimmunology: bone versus immune system. Nature 408, 535–536 (2000).
  Article CAS PubMed Google Scholar
• Schett, G. & David, J. P. The multiple faces of autoimmune-mediated bone loss. Nat. Rev. Endocrinol. 6, 698–706 (2010).
  Article CAS PubMed Google Scholar
• Schett, G. Saag, K. G. & Bijlsma, J. W. From bone biology to clinical outcome: state of the art and future perspectives. Ann. Rheum. Dis. 69, 1415–1419 (2010).
  Article CAS PubMed Google Scholar
• Sharp, J. T., Lidsky, M. D., Collins, L. C. & Moreland, J. Methods of scoring the progression of radiologic changes in rheumatoid arthritis. Correlation of radiologic, clinical and laboratory abnormalities. Arthritis Rheum. 14, 706–720 (1971).
  Article CAS PubMed Google Scholar
• Aletaha, D. et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/ European League Against Rheumatism collaborative initiative. Ann. Rheum. Dis. 69, 1580–1588 (2010).
  Article PubMed Google Scholar
• Ødegård, S. et al. Association of early radiographic damage with impaired physical function in rheumatoid arthritis: a ten-year, longitudinal observational study in 238 patients. Arthritis Rheum. 54, 68–75 (2006).
  Article PubMed Google Scholar
• Scott, D. L. et al. The links between joint damage and disability in rheumatoid arthritis. Rheumatology (Oxford) 39, 122–132 (2000).
  Article CAS Google Scholar
• Welsing, P. M., van Gestel, A. M., Swinkels, H. L., Kiemeney, L. A. & van Riel, P. L. The relationship between disease activity, joint destruction, and functional capacity over the course of rheumatoid arthritis. Arthritis Rheum. 44, 2009–2017 (2001).
  Article CAS PubMed Google Scholar
• McInnes, I. & Schett, G. Cytokines in the pathogenesis of rheumatoid arthritis. Nat. Immunol. 7, 429–442 (2007).
  Article CAS Google Scholar
• Stach, C.M. et al. Periarticular bone structure in rheumatoid arthritis patients and healthy individuals assessed by high-resolution computed tomography. Arthritis Rheum. 62, 330–339 (2010).
  PubMed Google Scholar
• Døhn, U. M. et al. Rheumatoid arthritis bone erosion volumes on CT and MRI: reliability and correlations with erosion scores on CT, MRI and radiography. Ann. Rheum. Dis. 66, 1388–1392 (2007).
  Article PubMed PubMed Central Google Scholar
• Wakefield, R. J. et al. The value of sonography in the detection of bone erosions in patients with rheumatoid arthritis: a comparison with conventional radiography. Arthritis Rheum. 43, 2762–2770 (2000).
  Article CAS PubMed Google Scholar
• McGonagle, D., Tan, A. L., Møller Døhn, U., Ostergaard, M. & Benjamin, M. Microanatomic studies to define predictive factors for the topography of periarticular erosion formation in inflammatory arthritis. Arthritis Rheum. 60, 1042–1051 (2009).
  Article PubMed Google Scholar
• Martel, W., Hayes, J. T. & Duff, I. F. The pattern of bone erosion in the hand and wrist in rheumatoid arthritis. Radiology 84, 204–214 (1965).
  Article CAS PubMed Google Scholar
• Ejbjerg, B. et al. Magnetic resonance imaging of wrist and finger joints in healthy subjects occasionally shows changes resembling erosions and synovitis as seen in rheumatoid arthritis. Arthritis Rheum. 50, 1097–1106 (2004).
  Article PubMed Google Scholar
• Tan, A. L. et al. Role of metacarpophalangeal joint anatomic factors in the distribution of synovitis and bone erosion in early rheumatoid arthritis. Arthritis Rheum. 48, 1214–1222 (2003).
  Article PubMed Google Scholar
• Hayer, S. et al. Tenosynovitis and osteoclast formation as the initial preclinical changes in a murine model of inflammatory arthritis. Arthritis Rheum. 56, 79–88 (2007).
  Article PubMed Google Scholar
• Marinova-Mutafchieva, L., Williams, R. O., Funa, K., Maini, R. N. & Zvaifler, N. J. Inflammation is preceded by tumor necrosis factor-dependent infiltration of mesenchymal cells in experimental arthritis. Arthritis Rheum. 46, 507–513 (2002).
  Article CAS PubMed Google Scholar
• Schett, G. et al. Analysis of the kinetics of osteoclastogenesis in arthritic rats. Arthritis Rheum. 52, 3192–3201 (2005).
  Article PubMed Google Scholar
• Tournis, S. et al. Effect of rheumatoid arthritis on volumetric bone mineral density and bone geometry, assessed by peripheral quantitative computed tomography in postmenopausal women treated with bisphosphonates. J. Rheumatol. 39, 1215–1220 (2012).
  Article CAS PubMed Google Scholar
• Aeberli, D. et al. Reduced trabecular bone mineral density and cortical thickness accompanied by increased outer bone circumference in metacarpal bone of rheumatoid arthritis patients: a cross-sectional study. Arthritis Res. Ther. 12, R119 (2010).
  Article PubMed PubMed Central Google Scholar
• Sharp, J. T. et al. Denosumab prevents metacarpal shaft cortical bone loss in patients with erosive rheumatoid arthritis. Arthritis Care Res. (Hoboken) 62, 537–544 (2010).
  Article Google Scholar
• Hoff, M. et al. Cortical hand bone loss after 1 year in early rheumatoid arthritis predicts radiographic hand joint damage at 5-year and 10-year follow-up. Ann. Rheum. Dis. 68, 324–329 (2009).
  Article CAS PubMed Google Scholar
• Haugeberg, G. et al. Hand cortical bone mass and its associations with radiographic joint damage and fractures in 50–70 year old female patients with rheumatoid arthritis: cross sectional Oslo-Truro-Amsterdam (OSTRA) collaborative study. Ann. Rheum. Dis. 63, 1331–1334 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Van der Heijde, D. M. Joint erosions and patients with early rheumatoid arthritis. Br. J. Rheumatol. 34, 74–78 (1995).
  Article PubMed Google Scholar
• Machold, K. P. et al. Very recent onset rheumatoid arthritis: clinical and serological patient characteristics associated with radiographic progression over the first years of disease. Rheumatology (Oxford) 46, 342–349 (2007).
  Article CAS Google Scholar
• Güler-Yüksel, M. et al. Changes in hand and generalised bone mineral density in patients with recent-onset rheumatoid arthritis. Ann. Rheum. Dis. 68, 330–336 (2009).
  Article PubMed Google Scholar
• Solomon, D. H. et al. The relationship between focal erosions and generalized osteoporosis in postmenopausal women with rheumatoid arthritis. Arthritis Rheum. 60, 1624–1631 (2009).
  Article PubMed PubMed Central Google Scholar
• Pye, S. R. et al. Disease activity and severity in early inflammatory arthritis predict hand cortical bone loss. Rheumatology (Oxford) 49, 1943–1948 (2010).
  Article Google Scholar
• Møller Døhn, U. et al. No overall progression and occasional repair of erosions despite persistent inflammation in adalimumab-treated rheumatoid arthritis patients: results from a longitudinal comparative MRI, ultrasonography, CT and radiography study. Ann. Rheum. Dis. 70, 252–258 (2011).
  Article Google Scholar
• Finzel, S. et al. A detailed comparative study of high-resolution ultrasound and micro-computed tomography for detection of arthritic bone erosions. Arthritis Rheum. 63, 1231–1236 (2011).
  Article PubMed Google Scholar
• Haavardsholm, E. A., Bøyesen, P., Østergaard, M., Schildvold, A. & Kvien, T. K. Magnetic resonance imaging findings in 84 patients with early rheumatoid arthritis: bone marrow oedema predicts erosive progression. Ann. Rheum. Dis. 67, 794–800 (2008).
  Article CAS PubMed Google Scholar
• McQueen, F. M. et al. Bone edema scored on magnetic resonance imaging scans of the dominant carpus at presentation predicts radiographic joint damage of the hands and feet six years later in patients with rheumatoid arthritis. Arthritis Rheum. 48, 1814–1827 (2003).
  Article PubMed Google Scholar
• Geusens, P. & Lems, W. F. Osteoimmunology and osteoporosis. Arthritis Res. Ther. 13, 242 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Finzel, S., Englbrecht, M., Engelke, K., Stach, C. & Schett, G. A comparative study of periarticular bone lesions in rheumatoid arthritis and psoriatic arthritis. Ann. Rheum. Dis. 70, 122–127 (2011).
  Article PubMed Google Scholar
• Bromley, M. & Woolley, D. E. Chondroclasts and osteoclasts at subchondral sites of erosion in the rheumatoid joint. Arthritis Rheum. 27, 968–975 (1984).
  Article CAS PubMed Google Scholar
• Leisen, J. C. D. H., Riddle, J. M. & Pitchford, W. C. The erosive front: a topographic study of the junction between the pannus and the subchondral plate in the macerated rheumatoid metacarpal head. J. Rheumatol. 15, 17–22 (1988).
  CAS PubMed Google Scholar
• Gravallese, E. M. et al. Identification of cell types responsible for bone resorption in rheumatoid arthritis and juvenile rheumatoid arthritis. Am. J. Pathol. 152, 943–951 (1998).
  CAS PubMed PubMed Central Google Scholar
• Kong, Y. Y. et al. Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature 402, 304–309 (1999).
  Article CAS PubMed Google Scholar
• Romas, E. et al. Osteoprotegerin reduces osteoclast numbers and prevents bone erosion in collagen-induced arthritis. Am. J. Pathol. 161, 1419–1427 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Lubberts, E. et al. Increase in expression of receptor activator of nuclear factor κB at sites of bone erosion correlates with progression of inflammation in evolving collagen-induced arthritis. Arthritis Rheum. 46, 3055–3064 (2002).
  Article CAS PubMed Google Scholar
• Pettit, A. R. et al. TRANCE/RANKL knockout mice are protected from bone erosion in a serum transfer model of arthritis. Am. J. Pathol. 159, 1689–1699 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Redlich, K. et al. Osteoclasts are essential for TNF-α-mediated joint destruction. J. Clin. Invest. 110, 1419–1427 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Redlich, K. et al. Tumor necrosis factor α-mediated joint destruction is inhibited by targeting osteoclasts with osteoprotegerin. Arthritis Rheum. 46, 785–792 (2002).
  Article CAS PubMed Google Scholar
• Yoshida, H. et al. The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene. Nature 345, 442–444 (1990).
  Article CAS PubMed Google Scholar
• Firestein, G. S. et al. Cytokines in chronic inflammatory arthritis. I. Failure to detect T cell lymphokines (interleukin 2 and interleukin 3) and presence of macrophage colony-stimulating factor (CSF-1) and a novel mast cell growth factor in rheumatoid synovitis. J. Exp. Med. 168, 1573–1586 (1988).
  Article CAS PubMed Google Scholar
• Wong, B. R. et al. TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells. J. Biol. Chem. 272, 25190–25194 (1997).
  Article CAS PubMed Google Scholar
• Yasuda, H. et al. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc. Natl Acad. Sci. USA 95, 3597–3602 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Lacey, D. L. et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93, 165–176 (1998).
  Article CAS PubMed Google Scholar
• Kong, Y.-Y. et al. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 397, 315–323 (1999).
  Article CAS PubMed Google Scholar
• Gravallese, E. M. et al. Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor. Arthritis Rheum. 43, 250–258 (2000).
  Article CAS PubMed Google Scholar
• Shigeyama, Y. et al. Expression of osteoclast differentiation factor in rheumatoid arthritis. Arthritis Rheum. 43, 2523–2530 (2000).
  Article CAS PubMed Google Scholar
• Li, P. et al. RANK signaling is not required for TNFα-mediated increase in CD11hi osteoclast precursors but is essential for mature osteoclast formation in TNFα-mediated inflammatory arthritis. J. Bone Miner. Res. 19, 207–213 (2004).
  Article CAS PubMed Google Scholar
• Ritchlin, C. T., Haas-Smith, S. A., Li, P., Hicks, D. G. & Schwarz, E. M. Mechanisms of TNF-α- and RANKL-mediated osteoclastogenesis and bone resorption in psoriatic arthritis. J. Clin. Invest. 111, 821–831 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Hermann, S. et al. OSCAR—a key co-stimulation molecule for osteoclasts is induced in patients with rheumatoid arthritis. Arthritis Rheum. 58, 3041–3050 (2008).
  Article CAS Google Scholar
• Ohno, H. et al. The orally-active and selective c-Fms tyrosine kinase inhibitor Ki20227 inhibits disease progression in a collagen-induced arthritis mouse model. Eur. J. Immunol. 38, 283–291 (2008).
  Article CAS PubMed Google Scholar
• Cohen, S. B. et al. Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis: a twelve-month, multicenter, randomized, double-blind, placebo-controlled, phase II clinical trial. Arthritis Rheum. 58, 1299–1309 (2008).
  Article CAS PubMed Google Scholar
• Visser, H., le Cessie, S., Vos, K., Breedveld, F. C. & Hazes, J. M. How to diagnose rheumatoid arthritis early: a prediction model for persistent (erosive) arthritis. Arthritis Rheum. 46, 357–365 (2002).
  Article PubMed Google Scholar
• Kastbom, A., Strandberg, G., Lindroos, A. & Skogh, T. Anti-CCP antibody test predicts the disease course during 3 years in early rheumatoid arthritis (the Swedish TIRA project). Ann. Rheum. Dis. 63, 1085–1089 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Meyer, O. et al. Anticitrullinated protein/peptide antibody assays in early rheumatoid arthritis for predicting five year radiographic damage. Ann. Rheum. Dis. 62, 120–126 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Shi, J. et al. Autoantibodies recognizing carbamylated proteins are present in sera of patients with rheumatoid arthritis and predict joint damage. Proc. Natl Acad. Sci. USA 108, 17372–17377 (2011).
  Article PubMed PubMed Central Google Scholar
• Harre, U. et al. Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin. J. Clin. Invest. 122, 1791–1802 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Wu, Y., Humphrey, M. B. & Nakamura, M. C. Osteoclasts—the innate immune cells of the bone. Autoimmunity 41, 183–194 (2008).
  Article CAS PubMed Google Scholar
• Ji, D. et al. Inhibition of RANK expression and osteoclastogenesis by TLRs and IFN-γ in human osteoclast precursors. J. Immunol. 183, 7223–7233 (2009).
  Article CAS PubMed Google Scholar
• Sato, K. et al. TH17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. J. Exp. Med. 203, 2673–2682 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Zaiss, M. M. et al. Regulatory T cells protect from local and systemic bone destruction in arthritis. J. Immunol. 184, 7238–7246 (2010).
  Article PubMed Google Scholar
• Zaiss, M. M. et al. Increased bone density and resistance to ovariectomy-induced bone loss in FoxP3-transgenic mice based on impaired osteoclast differentiation. Arthritis Rheum. 62, 2328–2338 (2010).
  Article CAS PubMed Google Scholar
• Axmann, R. et al. CTLA-4 directly inhibits osteoclast formation. Ann. Rheum. Dis. 67, 1603–1609 (2008).
  Article CAS PubMed Google Scholar
• Zaiss, M. M. et al. TREG cells suppress osteoclast formation: a new link between the immune system and bone. Arthritis Rheum. 56, 4104–4112 (2007).
  Article CAS PubMed Google Scholar
• Bakker, M. F. et al. Utrecht Rheumatoid Arthritis Cohort Study Group. Low-dose prednisone inclusion in a methotrexate-based, tight control strategy for early rheumatoid arthritis: a randomized trial. Ann. Intern. Med. 156, 329–339 (2012).
  Article PubMed Google Scholar
• Grigor, C. et al. Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial. Lancet 364, 263–269 (2004).
  Article PubMed Google Scholar
• Lam, J. et al. TNF-α induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand. J. Clin. Invest. 106, 1481–1488 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Boyce, B. F. et al. Effects of interleukin-1 on bone turnover in normal mice. Endocrinology 125, 1142–1150 (1989).
  Article CAS PubMed Google Scholar
• Zwerina, J. et al. TNF-induced structural joint damage is mediated by IL-1. Proc. Natl Acad. Sci. USA 104, 11742–11747 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Ishimi, Y. M. C. et al. IL-6 is produced by osteoblasts and induces bone resorption. J. Immunol. 145, 3297–3303 (1990).
  CAS PubMed Google Scholar
• Axmann, R. et al. Inhibition of interleukin-6 receptor directly blocks osteoclast formation in vitro and in vivo. Arthritis Rheum. 60, 2747–2756 (2009).
  Article CAS PubMed Google Scholar
• Poli, V. et al. Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion. EMBO J. 13, 1189–1196 (1994).
  Article CAS PubMed PubMed Central Google Scholar
• Jansen, L. M., van der Horst-Bruinsma, I. E., van Schaardenburg, D., Bezemer, P. D. & Dijkmans, B. A. Predictors of radiographic joint damage in patients with early rheumatoid arthritis. Ann. Rheum. Dis. 60, 924–927 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Kraan, M. C. et al. Asymptomatic synovitis precedes clinically manifest arthritis. Arthritis Rheum. 41, 1481–1488 (1998).
  Article CAS PubMed Google Scholar
• Van de Sande, M. G. et al. Different stages of rheumatoid arthritis: features of the synovium in the preclinical phase. Ann. Rheum. Dis. 70, 772–777 (2011).
  Article CAS PubMed Google Scholar
• Rich, E., Moreland, L. W. & Alarcón, G.S. Paucity of radiographic progression in rheumatoid arthritis treated with methotrexate as the first disease modifying antirheumatic drug. J. Rheumatol. 26, 259–261 (1999).
  CAS PubMed Google Scholar
• Schett, G., Stach, C., Zwerina, J., Voll, R. & Manger, B. How antirheumatic drugs protect joints from damage in rheumatoid arthritis. Arthritis Rheum. 58, 2936–2948 (2008).
  Article CAS PubMed Google Scholar
• Cohen, G. et al. Radiological damage in patients with rheumatoid arthritis on sustained remission. Ann. Rheum. Dis. 66, 358–363 (2007).
  Article CAS PubMed Google Scholar
• Molenaar, E. T. et al. Progression of radiologic damage in patients with rheumatoid arthritis in clinical remission. Arthritis Rheum. 50, 36–42 (2004).
  Article PubMed Google Scholar
• Brown, A. K. et al. An explanation for the apparent dissociation between clinical remission and continued structural deterioration in rheumatoid arthritis. Arthritis Rheum. 58, 2958–2967 (2008).
  Article CAS PubMed Google Scholar
• Vis, M. et al. Evaluation of bone mineral density, bone metabolism, osteoprotegerin and receptor activator of the NFκB ligand serum levels during treatment with infliximab in patients with rheumatoid arthritis. Ann. Rheum. Dis. 65, 1495–1499 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Pesu, M. et al. Therapeutic targeting of Janus kinases. Immunol. Rev. 223, 132–142 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• van Vollenhoven, R. F. et al. Tofacitinib or adalimumab versus placebo in rheumatoid arthritis. N. Engl. J. Med. 367, 508–519 (2012).
  Article CAS PubMed Google Scholar
• Fleischmann, R. et al. Placebo-controlled trial of tofacitinib monotherapy in rheumatoid arthritis. N. Engl. J. Med. 367, 495–507 (2012).
  Article CAS PubMed Google Scholar
• Weinblatt, M. E. et al. An oral spleen tyrosine kinase (Syk) inhibitor for rheumatoid arthritis. N. Engl. J. Med. 363, 1303–1312 (2010).
  Article CAS PubMed Google Scholar
• Mócsai, A. et al. The immunomodulatory adapter proteins DAP12 and Fc receptor γ-chain (FcRγ) regulate development of functional osteoclasts through the Syk tyrosine kinase. Proc. Natl Acad. Sci. USA 101, 6158–6163 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• McInnes, I. B. & Schett, G. The pathogenesis of rheumatoid arthritis. N. Engl. J. Med. 365, 2205–2219 (2011).
  Article CAS PubMed Google Scholar
• Jiang, Y. et al. A multicenter, double-blind, dose-ranging, randomized, placebo-controlled study of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis: radiologic progression and correlation of Genant and Larsen scores. Arthritis Rheum. 43, 1001–1009 (2000).
  Article CAS PubMed Google Scholar
• Fossiez, F. et al. T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J. Exp. Med. 183, 2593–2603 (1996).
  Article CAS PubMed Google Scholar
• Jovanovic, D. V. et al. IL-17 stimulates the production and expression of proinflammatory cytokines, IL-β and TNF-α, by human macrophages. J. Immunol. 160, 3513–3521 (1998).
  CAS PubMed Google Scholar
• Chabaud, M. et al. Human interleukin-17: a T cell-derived proinflammatory cytokine produced by the rheumatoid synovium. Arthritis Rheum. 42, 963–970 (1999).
  Article CAS PubMed Google Scholar
• Miossec, P., Korn, T. & Kuchroo, V. K. Interleukin-17 and type 17 helper T cells. N. Engl. J. Med. 361, 888–889 (2009).
  Article CAS PubMed Google Scholar
• Kotake, S. et al. IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J. Clin. Invest. 103, 1345–1352 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Sato, K. et al. TH17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. J. Exp. Med. 203, 2673–2682 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Zwerina, K. et al. Anti IL-17A therapy inhibits bone loss in TNF-α-mediated murine arthritis by modulation of the T-cell balance. Eur. J. Immunol. 42, 413–423 (2012).
  Article CAS PubMed Google Scholar
• Ogata, Y. et al. A novel role of IL-15 in the development of osteoclasts: inability to replace its activity with IL-2. J. Immunol. 162, 2754–2760 (1999).
  CAS PubMed Google Scholar
• Knevel, R. et al. Genetic variants in IL15 associate with progression of joint destruction in rheumatoid arthritis: a multicohort study. Ann. Rheum. Dis. 71 (Suppl. 1), A56–A57 (2012).
  Google Scholar
• Zaiss, M. M. et al. IL-33 shifts the balance from osteoclast to alternatively activated macrophage differentiation and protects from TNFα-mediated bone loss. J. Immunol. 186, 6097–6105 (2011).
  Article CAS PubMed Google Scholar
• Quinn, J. M. et al. IL-23 inhibits osteoclastogenesis indirectly through lymphocytes and is required for the maintenance of bone mass in mice. J. Immunol. 181, 5720–5729 (2008).
  Article CAS PubMed Google Scholar
• Lukas, C., van der Heijde, D., Fatenejad, S. & Landewé, R. Repair of erosions occurs almost exclusively in damaged joints without swelling. Ann. Rheum. Dis. 69, 851–855 (2010).
  Article PubMed Google Scholar
• Møller Døhn, U. et al. Erosive progression is minimal, but erosion healing rare, in patients with rheumatoid arthritis treated with adalimumab. A 1-year investigator-initiated follow-up study using high-resolution computed tomography as the primary outcome measure. Ann. Rheum. Dis. 68, 1585–1590 (2009).
  Article CAS PubMed Google Scholar
• Finzel, S. et al. Interleukin-6 receptor blockade induces limited repair of bone erosions in rheumatoid arthritis: a micro CT study. Ann. Rheum. Dis. http://dx.doi.org/10.1136/annrheumdis-2011-201075.
• Finzel, S. et al. Repair of bone erosions in rheumatoid arthritis treated with tumour necrosis factor inhibitors is based on bone apposition at the base of the erosion. Ann. Rheum. Dis. 70, 1587–1593 (2011).
  Article CAS PubMed Google Scholar
• Walsh, N. C. et al. Osteoblast function is compromised at sites of focal bone erosion in inflammatory arthritis. J. Bone Miner. Res. 24, 1572–1585 (2009).
  Article CAS PubMed Google Scholar
• Diarra D, Stolina M, Polzer K. et al. Dickkopf-1 is a master regulator of joint remodeling. Nat. Med. 13, 156–163 (2007).
  Article CAS PubMed Google Scholar
• Matzelle, M. M. et al. Resolution of inflammation induces osteoblast function and regulates the Wnt signaling pathway. Arthritis Rheum. 64, 1540–1550 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Redlich, K. et al. Repair of local bone erosions and reversal of systemic bone loss upon therapy with anti-tumor necrosis factor in combination with osteoprotegerin or parathyroid hormone in tumor necrosis factor-mediated arthritis. Am. J. Pathol. 164, 543–555 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Poole, K. E. et al. Sclerostin is a delayed secreted product of osteocytes that inhibits bone formation. FASEB J. 19, 1842–1844 (2005).
  Article CAS PubMed Google Scholar
• Semënov, M., Tamai, K. & He, X. SOST is a ligand for LRP5/LRP6 and a Wnt signaling inhibitor. J. Biol. Chem. 280, 26770–26775 (2005).
  Article CAS PubMed Google Scholar